Mucocutaneous manifestations in COVID-19 affected children: JAAD Study Dr Manoj Kumar Nayak21 Aug 2021 3:30 AM GMTThe present COVID pandemic due to SARSCoV- 2 is one of the most severe influenza pandemic seen till date. Multisystem inflammatory syndrome in...
Colchicine, a potential first-line treatment for cutaneous polyarteritis nodosa: Study Medha9 Aug 2021 2:45 PM GMTParis: Colchicine is a reasonable first-line treatment for cutaneous polyarteritis nodosa (cPAN) without peripheral sensory neuropathy and has a...
Ixekizumab most efficacious immunodulator therapy for nail psoriasis, finds Study Meghna A Singhania1 July 2021 5:30 AM GMTPsoriasis is a chronic immune-mediated inflammatory disease that affects the skin and joints, with associated comorbidities. Approximately 80% of...
